Illumina, Inc. Files 2024 10-K

TL;DR

Illumina's 2024 10-K is in. Full financials for the year ending Dec 29, 2024, are now public.

AI Summary

Illumina, Inc. filed its 2024 10-K report on February 12, 2025, detailing its fiscal year ending December 29, 2024. The company, a leader in laboratory analytical instruments, is incorporated in Delaware and headquartered in San Diego, California. The filing covers financial performance and business operations for the fiscal year 2024.

Why It Matters

This 10-K filing provides a comprehensive overview of Illumina's financial health and strategic direction for the fiscal year 2024, offering insights for investors and stakeholders.

Risk Assessment

Risk Level: medium — The filing of a 10-K is a routine requirement for public companies, but the content within can reveal significant financial and operational risks.

Key Numbers

• 2024 — Fiscal Year (Reporting period for the 10-K)
• 2024-12-29 — Fiscal Year End Date (End of the reporting period)
• 2025-02-12 — Filing Date (Date the 10-K was submitted to the SEC)

Key Players & Entities

• ILLUMINA, INC. (company) — Filer
• 2024-12-29 (date) — Fiscal Year End
• 2025-02-12 (date) — Filing Date
• San Diego, CA (location) — Headquarters
• 3826 (industry_code) — Standard Industrial Classification

FAQ

Key Financial Figures

• $0.01 — ange on which registered Common Stock, $0.01 par value ILMN The Nasdaq Stock Market
• $200 — equence a human genome for as little as $200. In 2024, we launched the benchtop MiSe

Filing Documents

• ilmn-20241229.htm (10-K) — 2304KB
• ex191insidertradingpolicy.htm (EX-19.1) — 63KB
• fy2410-kex211subsidiariesq4.htm (EX-21.1) — 37KB
• ex231consentfy2410-kq4.htm (EX-23.1) — 3KB
• fy24q4ex311.htm (EX-31.1) — 15KB
• fy24q4ex312.htm (EX-31.2) — 14KB
• fy24q4ex321.htm (EX-32.1) — 7KB
• fy24q4ex322.htm (EX-32.2) — 7KB
• ilmn-20241229_g1.jpg (GRAPHIC) — 7KB
• ilmn-20241229_g2.gif (GRAPHIC) — 13KB
• ilmn-20241229_g3.jpg (GRAPHIC) — 665KB
• ilmn-20241229_g4.jpg (GRAPHIC) — 100KB
• 0001110803-25-000019.txt ( ) — 15522KB
• ilmn-20241229.xsd (EX-101.SCH) — 90KB
• ilmn-20241229_cal.xml (EX-101.CAL) — 132KB
• ilmn-20241229_def.xml (EX-101.DEF) — 543KB
• ilmn-20241229_lab.xml (EX-101.LAB) — 1104KB
• ilmn-20241229_pre.xml (EX-101.PRE) — 833KB
• ilmn-20241229_htm.xml (XML) — 2084KB

Legal Proceedings

Legal Proceedings 28 Market Information 28 Share Repurchases and Sales 30 MANAGEMENT'S DISCUSSION & ANALYSIS Management's Overview and Outlook 31 Results of Operations 34 Liquidity and Capital Resources 38 Critical Accounting Policies and Estimates 40

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 45 Recent Accounting Pronouncements 46 CONSOLIDATED FINANCIAL STATEMENTS Index to Consolidated Financial Statements 47 Report of Independent Registered Public Accounting Firm 48 Consolidated Balance Sheets 50 Consolidated Statements of Operations 51 Consolidated Statements of Comprehensive Loss 52 Consolidated Statements of Stockholders' Equity 53 Consolidated Statements of Cash Flows 54

Notes to Consolidated Financial Statements

Notes to Consolidated Financial Statements 55 OTHER KEY INFORMATION

Controls and Procedures

Controls and Procedures 95 Adoptions, Modifications or Terminations of Trading Plans 97 Directors, Executive Officers and Corporate Governance 98

Executive Compensation

Executive Compensation 98

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 98 Certain Relationships and Related Transactions, and Director Independence 99 Principal Accountant Fees and Services 99 Exhibits, Financial Statement Schedules 99 Form 10-K Cross-Reference Index 105 See "Form 10-K Cross-Reference Index" within Other Key Information for a cross-reference to the parts and items requirements of the Securities and Exchange Commission Annual Report on Form 10-K. 1 Consideration Regarding Forward-Looking Statements This annual report on Form 10-K contains, and our officers and representatives may from time to time make, "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Words such as: "anticipate," "intend," "plan," "goal," "seek," "believe," "continue," "project," "estimate," "expect," "strategy," "future," "likely," "may," "potential," "predict," "should," "will," or similar words or phrases, or the negatives of these words, may identify forward-looking statements, but the absence of these words does not necessarily mean that a statement is not forward looking. Examples of forward-looking statements include, among others, statements we make regarding: our expectations as to our future financial performance, results of operations, or other operational results or metrics; the benefits that we expect will result from our business activities and certain transactions we have completed, or may complete, such as product introductions, increased revenue, decreased expenses, and avoided expenses and expenditures; our expectations of the effect on our financial condition of claims, litigation, contingent liabilities, and governmental investigations, proceedings, and regulations; our strategies or expectations for product development, market position, financial results, and reserves; our ability to successfully implement cost reduction plans

View Full Filing

View this 10-K filing on SEC EDGAR